Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Novartis Ag (NVSEF) Return on Equity (2018 - 2025)

Historic Return on Equity for Novartis Ag (NVSEF) over the last 7 years, with Q1 2025 value amounting to 0.66%.

  • Novartis Ag's Return on Equity changed N/A to 0.66% in Q1 2025 from the same period last year, while for Mar 2025 it was 0.66%, marking a year-over-year change of. This contributed to the annual value of 0.31% for FY2025, which is 500.0% up from last year.
  • Latest data reveals that Novartis Ag reported Return on Equity of 0.66% as of Q1 2025.
  • Over the past 5 years, Novartis Ag's Return on Equity peaked at 11.97% during Q2 2021, and registered a low of 0.09% during Q1 2023.
  • Its 4-year average for Return on Equity is 2.42%, with a median of 0.68% in 2023.
  • As far as peak fluctuations go, Novartis Ag's Return on Equity skyrocketed by 4300bps in 2022, and later crashed by -6800bps in 2023.
  • Quarter analysis of 4 years shows Novartis Ag's Return on Equity stood at 11.97% in 2021, then plummeted by -94bps to 0.77% in 2022, then decreased by -9bps to 0.7% in 2023, then decreased by -5bps to 0.66% in 2025.
  • Its Return on Equity stands at 0.66% for Q1 2025, versus 0.7% for Q2 2023 and 0.09% for Q1 2023.